Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Sorrento Therapeutics
Sorrento Therapeutics
Sorrento and Yuhan Secure $40 Million for Immuno-Oncology Joint Venture
CP Wire
Tue, 02/12/19 - 10:02 am
Sorrento Therapeutics
Yuhan
ImmuneOncia
immuno-oncology
Sorrento and Yuhan Secure $40 Million for Immuno-Oncology Joint Venture
Tue, 02/12/19 - 09:55 am
Sorrento Therapeutics
Yuhan
ImmuneOncia
immuno-oncology
Sorrento shows fast, durable arthritis pain relief with ‘spicy’ injection in early study
Fierce Biotech
Tue, 01/22/19 - 12:00 pm
Sorrento Therapeutics
osteoarthritis of the knee
clinical trials
Resiniferatoxin
capsaicin
Scilex Raises $140 Million to Support Commercialization of Non-Opioid Topical Pain Medication System
CP Wire
Mon, 09/10/18 - 09:50 am
Sorrento Therapeutics
Scilex
lidocaine
Scilex Raises $140 Million to Support Commercialization of Non-Opioid Topical Pain Medication System
Mon, 09/10/18 - 09:13 am
Sorrento Therapeutics
Scilex
Sorrento Therapeutics wins FDA nod for post-shingles pain patch
Drug Delivery Business News
Wed, 02/28/18 - 06:45 pm
Sorrento Therapeutics
FDA
shingles
ZTlido
post-shingles neuralgia
3 Biotech Stocks That Soared This Week
Motley Fool
Sun, 02/18/18 - 10:09 am
Alkermes
Immunogen
Sorrento Therapeutics
3 Biotech Stocks That Soared This Week: Are They Buys?
Motley Fool
Sun, 10/15/17 - 12:38 pm
biotech
AnaptysBio
Sorrento Therapeutics
Ardelyx
Sorrento Therapeutics Gets FDA Go-Ahead for Cancer Pain Clinical Trial
Xtalks
Thu, 07/6/17 - 09:39 am
Sorrento Therapeutics
clinical trials
FDA
cancer pain
Resiniferatoxin
Sorrento’s new pain player Scintilla going solo after $200M buyout deal
Endpoints
Tue, 08/16/16 - 09:16 am
Sorrento Therapeutics
Scintilla
Semnur Pharmaceuticals
M&A
Sorrento launches another joint venture with a $170M cancer deal
Fierce Biotech
Mon, 09/28/15 - 11:54 am
Sorrento Therapeutics
R&D
cancer
antibodies
Could This Tiny Company Threaten Celgene?
Investopedia
Fri, 06/12/15 - 10:47 pm
Celgene
Sorrento Therapeutics
Abraxane
Sorrento Reaches Collaboration Deal Valued at $110 Million
WSJ Online
Mon, 03/16/15 - 04:39 pm
Sorrento Therapeutics
cancer immunotherapy
3 Compelling Oncology Biotechs From Rodman & Renshaw 2013
Seeking Alpha
Thu, 09/12/13 - 10:22 am
oncology
Rodman & Renshaw
CytRx
Sorrento Therapeutics
Champions Oncology
Pages
« first
‹ previous
1
2